Li Zhi

Li Zhi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DGDongmei Gou
Dongmei Gou
RLRui Liu
Rui Liu
XSXiaoqun Shan
Xiaoqun Shan
HDHaijun Deng
Haijun Deng
CCChang Chen
Chang Chen
NTNi Tang
Ni Tang
Deciphering the crosstalk between metabolic reprogramming and epigenetic regulation is a promising strategy for cancer therapy. In this study, we discovered that the gluconeogenic enzyme PCK1 fueled the generation of S-adenosylmethionine (SAM) through the serine synthesis pathway. The methyltransferase SUV39H1 catalyzed SAM, which served as a methyl donor to support H3K9me3 modification, leading to the suppression of the oncogene S100A11. Mechanistically, PCK1 deficiency–induced oncogenic activation of S100A11 was due to its interaction with AKT1, which upregulated PI3K/AKT signaling. Intriguingly, the progression of hepatocellular carcinoma (HCC) driven by PCK1 deficiency was suppressed by SAM supplement or S100A11 KO in vivo and in vitro. These findings reveal the availability of the key metabolite SAM as a bridge connecting the gluconeogenic enzyme PCK1 and H3K9 trimethylation in attenuating HCC progression, thus suggesting a potential therapeutic strategy against HCC.

1 November 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
YHYan Huang
Yan Huang
FLFeng Liu
Feng Liu
ACA-Mei Chen
A-Mei Chen
PYPeng-Fei Yang
Peng-Fei Yang
YPYang Peng
Yang Peng
GZGuo-Chao Zhong
Guo-Chao Zhong